RAD51
MOLECULAR TARGETRAD51 recombinase
RAD51 (RAD51 recombinase) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting RAD51
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Dactinomycin | 0.69 | 1 |
About RAD51 as a Drug Target
RAD51 (RAD51 recombinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented RAD51 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
RAD51 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.